Thermography, a pictorial display of the infrared radiation of the breast, has been used for approximately 25 years as an aid in the evaluation of breast problems. Its inception dates to Lawson's observations in 1956-1958 that a breast cancer may be warmer than surrounding tissue.'-' He also showed that the venous blood draining the cancer may be warmer than its arterial supply.
METHOD
Fourteen experienced thermographers from the United States were contacted concerning this proposed study; ten agreed to participate in the evaluation. A computer analysis and interpretation of the thermograms was also performed and will be presented in a later evaluation.
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The ten experienced thermographers blindly read 576 thermograms from 5 15 screenees of the Breast Cancer Detection Demonstration Project at Ann Arbor, Michigan. These women were selected from our screening population to meet several criteria for various groups. This selection was conducted randomly using either the BCDDP accession (enrollment) book and/or the pathology code and follow-up book.
The women were randomly chosen for these various groupings. The thermograms were not reviewed or selected. All cancer screenees known and verified through March 1977 were included.
Each reader performed the following tasks for each thermogram: (1) graded each thermogram as to quality (poor, fair, good, or excellent), (2) graded each thermogram as to readability (readable, nonreadable), (3) assessed each breast as normal, equivocal, or abnormal, (4) made a recall recommendation (immediate, six month, or twelve month), and ( 5 ) stated a confidence level for the reading [from one (low) to five (high)]. Five thermographers reread the thermograms; this reproducibility assessment will be considered separately. Calculations presented in the following tables are based solely on the first reading, unless otherwise stated. The thermograms were divided into five major groups:
(1) Randomly selected group: A group of 200 screenees representative of the entire 10,000-woman screening population of the University of Michigan BCDDP was selected randomly by accession number. The women in this group are distributed throughout the various other groups described below, but were so identified that projections could be made as to the false positive/true positive rates for thermography for an asymptomatic (screening) population. For example, from this group, I16 screenees represent a pristine "normal" group with no previous or subsequent (during four years of follow-up) breast abnormalities. These 1 16 women were also included in the normal group discussed below.
(2) Normal group: The 271 women in this category were determined to have no significant abnormality at the time the thermogram that is included in the study was taken. A normal classification was based on screening by mammography and physical examination. These women have been screened and followed for four years and have
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Annals New York Academy of Sciences no known breast cancer. However, 91 of these 271 women were found, on subsequent screening, to have some abnormality. Although, for the majority of these, the abnormalities were considered benign or insignificant, these 91 women have been excluded from this analysis. An abnormal call on the thermogram in the remaining 180 women is considered a false positive.
(3) Cancer; All screenees with cancers detected and verified at the University of Michigan BCDDP as of March, 1977 were included in this study. The cancer population consists of two groups: (1 ) the prevalent cancer group, cancers detected on the first screening visit, and (2) the incident cancer group, cancers detected on subsequent screening visits.
(4) Precancer group: This group consists of thermograms obtained during previous screening visits prior to the detection and verification of cancer in the incident cancer group.
( 5 ) Abnormal (noncancer) group: Women in this group have a breast abnormality, but have not been documented to have breast cancer over the last four years. This group consists of three categories: ( I ) abnormal physical examination, normal mammogram; (2) abnormal mammogram, normal physical examination; (3) abnormal mammogram and physical examination.
After the individual screenees were selected, their thermograms were randomly assigned positions within the study. The thermograms were then copied onto 10 x 12 in. (25 x 30 cm) sheets of duplicating film. This process was begun in March 1977 and the final thermographic interpretations were accomplished in December 1978. This long time interval for completion of this study introduced some unanticipated factors; i.e., reassignment of screenees to different groups as their medical history changed.
Our analyses considered the number and percentage of abnormal interpretations for each group. We have used the standards applied in the Breast Cancer Detection Demonstration Project for assessment; i.e., early recall (immediate or six-month re-evaluation) is considered a significant recommendation. Therefore, an equivocal reading with an early recall recommendation is considered abnormal; whereas an equivocal reading with a 12-month recall is considered normal. An abnormal reading with a 12-month recall is considered normal. Therefore, an abnormal interpretation in this analysis is either ( I ) an abnormal call with an early recall recommended, or (2) an equivocal call with an early recall recommended. In this way, the true positive/false positive ratio can be determined for each abnormal group. An abnormal call in each abnormal group was considered a true positive and each group was analyzed separately.
A false positive is an abnormal call for a thermogram in the nortiral group only. This is evaluated for several groups: ( I ) the random group (200). (2) the random group of normals ( 1 16), and (3) a total normal group (180) who have no subsequent recommendation on either specific testing modality. Thermograms considered nonreadable were excluded from the analysis for each individual redder. Thus, the number of thermograms considered in each reader's analysis varies.
To evaluate the performance of the readers, both individually and as a group, Relative Operating Characteristic curves (ROC curves) and the Detectability Index (d')'7*22 were obtained, based on the true positive/false positive ratio of our cancer and normal populations. The Detectability Index. d' = difference in means/variance. is a way of assessing how two populations (normal and abnormal) can be separated. A high value of d' indicates good separation of two populations. Revesz19 reported a detectability index for therrnography of 2.0 based on earlier reported data. False positive and false negative values for mammography and clinical examinations in one study" produced detectability indices of 1.4 and 1.7, respectively, while that of thermography was 1.6. These values were obtained from an analysis of data derived from evaluations of symptomatic patients rather than from a screened, selfvolunteered population as is done here. This point will be discussed in greater detail later in the paper.
Three other statistical procedures have been used to evalute the performance of the readers. These are the Odds Ratio (Mantel-Haenszel techniq~e).~'*~' the Chi- Haenszel method pools in a systematic way, the discrimination performance of each reader into the odds ratio and is a better measure of the results than using the observed average true positive to false positive ratio.
The Cochran test (chi-square), which measures the association among the ten readers, was used to determine whether the readers individually, and as a group, could discriminate between the normal and abnormal populations.
Finally, the kappa (K) statistic measures in a qualitative way, the intrareader reproducibility and the interreader agreement. The kappa statistic generally varies from 0 to 1. Here, the quantity kappa is defined as
where f, is the observed proportion of agreement and P, is the proportion of agreement expected by chance. If K is zero, or small, then any agreement between two distributions occur merely by chance; K equals one when there is perfect agreement. The I[ value can become negative to indicate a negative correlation. considered poor, 69% fair or good, and 2% excellent. In general, there was good agreement among the various readers on the quality of the thermograms.
RESULTS

Quality of Thermograms
The results of the second readings are also given in TABLE 2. The kappa values are low, ranging from 0.1 15 to 0.349 (1.0 indicates perfect agreement). The low kappa values are somewhat misleading since a majority of the thermograms were assigned to an adjacent category on the second reading when compared to the first. The contingency table for the quality rating of the thermograms for the two readings by reader 5 shows this (TABLE 3) . The tally for the first reading is listed by column and the tally for the second is listed by row. The diagonal entries correspond to thermograms rated the same for the two readings. The solid lines separate the The number and percentages of therrnograms from our normal group that were called abnormal is given in column 1 of TABLE 6. This group consists of women 
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, The percentages of abnormal calls for the abnormal groups are given in columns 2-7 of TABLE 6. An abnormal call in these groups is considered a true positive and each group is treated separately. The percentage of abnormal calls for the prevalent and incident cancer populations is listed in columns 2 and 3, respectively. The percentage of true positive calls for the prevalent cancers, averaged over all ten readers, is 0.53. The corresponding rate for the incident cancer group is 0.44. These numbers should be compared to the false positive rate for the normal population of 0.38.
An assessment of each reader's performance in detecting the cancer population is shown graphically in FIGURES 1 and 2. The true positive (cancers) percentages for the prevalent (FIGURE 1) and incident (FIGURE 2) cancer populations with thc false positive rate (normal) for each reader are plotted. The index of detectability for each reader and the mean index of detectability are also shown. For the prevalent cancer population all ten readers were above the random or guessing line (d' -0) but no one 51 1 reader was above a d' value of 0.75. Although the detectability was low, a chi-square test determined that all readers but 5, 8, and 10 were significantly (ptO.lO) above the (guessing) line. The mean detectability was 0.5 for all ten readers. The individual performances in detecting the incident cancers were, in general, considerably poorer. There was a significant difference (pt0.10) in the abnormal calls for the normal and incident cancer populations for only two of the readers (7 and 9). Four of the readers called the same (or a lesser) percentage of the incident cancers abnormal than for the normals. The mean detectability for the incident cancers was less than 0.25. It is interesting that although the individual percentage of abnormal calls varied greatly (10%-90%), the individual true positive/false positive ratios and d' values were very similar and varied little about the mean. This, of course, implies that no one reader did significantly better or worse than any other.
For the three abnormal groups other than the cancer populations, the trend in the percentage of abnormal calls corresponded somewhat to the degree of the abnormality. The true positive/false positive ratio is 1.00 for the abnormal physical examination group, 1.24 for the abnormal mammogram group, and 1.47 for the abnormal mammogram and physical examination group. Thus, there is some evidence that an abnormal breast (other than one containing a cancer) can result in an abnormal thermogram. However, it should be emphasized that in this group as with the cancer group, the detectability is low.
The percentage of abnormal calls for the precancer group (0.45) is similar to that found for the incident cancers (0.44); the detectability is correspondingly low. This, in some measure, addresses the question as to whether thermography can detect a high risk group or can be used as a high risk indicator. These data provide little support for either concept.
The calculated odds ratio for the different populations (TABLE 7) range from 1 .O for the abnormal physical examination group to 2.2 for the abnormal mammogram and physical examination group. The odds ratio for the prevalent cancer group is 2.0. This can be interpreted as meaning that, averaged over all readers, the odds are 2 to 1 that a thermogram that is called abnormal on an initial screening does, in fact, represent a cancer. However, it should be mentioned that a similar calculation based on results from mammography from our own data gives an odds ratio of approximately 18.
True Positive/False Positive Ratio for Good and Excellent Quality Thermograms
We questioned whether the technical quality of the thermograms contributed to these generally poor results ( positive/false positive ratio and the odds ratio. The true positive/false positive ratio was 1.34 for the prevalent cancer group as compared to 1.39 when all quality thermograms were considered. Thus, there is a slight decrease in the true positive/false positive ratio. The calculated odds ratio (using only good and excellent thermograms) is 1.94 compared to 2.04 when all quality thermograms are considered. These data do not support the concept that the technical quality of the thermogram plays a significant role in the low level of detectability of significant breast abnormalities by thermography.
Reproducibiliiy of Normal/Abnormal Calls
TABLE 9 shows the contingency tables for the five readers that reread the thermograms. Each 2 x 2 table represents the agreement and disagreement for the normal and abnormal calls for the two readings. The numbers in the diagonal correspond to the number of thermograms that had the same interpretation for the two readings. The two off-diagonal entries correspond to the number of thermograms that had different interpretations. The corresponding kappa values are also listed in TABLE 9. The kappa values varied from 0.290 to 0.623. An assessment of the reader(s) performance can be summarized in the following way: Reader 2, with the highest kappa value (0.623). called 176 thermograms abnormal on the first reading; only 13 1 of these same thermograms or 74% were called abnormal on the second reading. Reader 5, with the lowest kappa value (0.294), called 134 thermograms abnormal on the first reading; only 51 or 38% of these same thermograms were called abnormal on the second reading. These data represent, in general, very low kappa values and may derive from the lack of precise, objective criteria for thermographic evaluation. cancers detected.
Influence of Size and Histologic Type on True Positive Calls
The cancer population in this study differs significantly from that found in usual clinical practice. This is true for both the size of the cancers and the distribution of histologic types. TABLE 10 is a comparison of the histologic staging for the breast cancer patients of the University of Michigan Breast Cancer Detection Demonstration Project as compared with metropolitan Detroit breast cancer patients. More than 45% of the BCDDP cancers were in sifu lesions as compared to only 4.2% found in the Detroit population. The Detroit population accurately reflects the usual distribution of histologic types of cancer found in a symptomatic population. In addition, there is a notable difference in the histologic staging of our prevalent and incident cancer populations. The distributions for our prevalent and incident cancer populations are given in TABLE I I . Here, a striking shift toward detection of in situ lesions is shown for the incident cancer group. When comparing the results of these thermographic evaluations to those previously reported from symptomatic patients, the influence of both size and histologic type of the cancers on the true positive rate must be assessed. Our total cancer population includes only 26 cancers greater than 2 cm in diameter. The usual cancer found in symptomatic patients will average 2-4 cm in diameter, at least on clinical examination (the usual way of reporting such information). So, our population, even in the prevalent cancer group, is significantly different, both in size and histologic type, from the usual cancer group that is seen and reported by clinicians.
The cancer population was divided into two groups (cancers greater or less than 1 cm in diameter) to determine to what extent the size of the cancer influences the true positive rate. Cancers greater than 2 cm in diameter were considered separately. The percentage of true positive calls for the cancer population separated according to these criteria is given in TABLE 12. The percentage of true positive calls (averaged over all readers) was 0.56 for cancers greater than 2 cm, 0.55 for cancers greater than 1 cm (this group includes the greater than 2 cm group), and 0.47 for the cancers less than 1 cm. Thus, there seems to be a slight improvement in the true positive call rate of the cancers with increasing size of the cancer. This difference may account for the difference in the true positive call rates of our prevalent and incident cancer populations; however, the detectability for the larger cancers is still low.
The true positive rate for six different histologic types is given in TABLE 13. These six histologic types represent the predominant cancer categories within our cancer population. The sizes of the cancer are not considered in this particular analysis. There is increasing accuracy of true positive calls when in situ cancers are compared with invasive cancers. This mirrors the difference of the prevalent and incident cancer populations in that the incident cancers have a considerably higher percentage of in situ cancers. There seems to be little variation in the true positive calls for the invasive cancers, other than for the invasive lobular carcinoma. These data suggest that thermography has a low level of detectability for small cancers or those that are in situ. These data further demonstrate an increasing accuracy of thermography as the cancer increases in size or aggressiveness. These factors function in the same way for other testing modalities, i.e., physical examination and mammography. The problem for clinicians is detecting a breast cancer in a small size with the least (or no) invasion so that the possibility of cure can be greatest. It has been hoped that thermography could detect such small lesions, by their biologic activity, prior to their presentation as the usual clinical or mammographic mass. Our data does not support this concept. Comparison of these results with published reports is somewhat difficult in that few reports provide specific data as to histologic size and type of the cancer population. Stark" describes abnormal thermograms in patients with invasive carcinoma, lobular carcinoma in siru. and intraductal carcinoma, but specific sizes of the cancers are not noted. Her data seems to cover both prevalent and incident cancers, and the number of cancers reported is small (59 cancers). MoskowitzM specifically limited his discussion to Stage I and minimal cancer screenees, but did not specify as to whether they were incident or prevalent cancers.
It seems that thermography, like other testing modalities, has increasing accuracy with increasing size of the cancers. The finding of such small cancers as in our population may not truly represent the usual Occurrence in a general population. Thermography may offer some value in a one-time screen of the general population since more cancers of a larger size may be present and may not be palpable.
CONCLUSION
Averaged over all thermogram readers, there is a statistically significant separation (pt0.10) between our normal population and the different abnormal groups, with the exception of the group abnormal with a physical examination. However, the detectability of these significant breast abnormalities, benign or malignant, is much less than expected. Overall, the readers did better in detecting (1) the prevalent cancers, and (2) screenees with no cancers but with a concurrent abnormal mammogram and physical examination.
Our results indicate that in situ cancers cannot be selected from a population with better than random results. However, the true positive rate improves for the invasive cancers and for cancers large in size. Under the best conditions (i.e., cancers with positive nodes read by the best five of the ten readers) the index of detectability (d') is found to be 1.2. No single factor considered (cancer size, histologic type, quality of thermogram) improves the detectability index beyond 1.2. The d' for the prevalent cancer population that may be comparable to the cancers found in an initial screening of a general population was less than 0.5.
There is a large variation in the sensitivity of our readers. For example, the number of thermograms called abnormal varied from 65 to 327. No explanation has been found for this large variation. In addition, intrareader reproducibility in respect to the normal-abnormal distribution is low overall. An investigation of the "precancer" thermograms (thermograms obtained on screening visits prior to determination of a breast cancer) has indicated that thermography cannot be used as a risk indicator for breast cancer.
Although the data is not presented here, the thermograms in this study were also analyzed by computerized pattern recognition. The resulting true positive/false positive ratios were smaller than those obtained by the human readers; specific programming problems related to our study format may have contributed to these low results. The results of this study will be presented a t a later date. Further investigation of computerized analysis of these thermograms is also planned.
For thermography to serve a useful purpose, two problems must be addressed: ( I ) the level of detectability, and (2) reproducibility. Certainly, computerized pattern recognition would seem the solution to the reproducibility problems. But, determining criteria and factors that will increase the level of detectability, especially for small cancers, seems to be the prime problem with the technique. Further investigation of these aspects should be pursued to determine if thermography can be made effective as a tool for the detection of breast cancer.
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